Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00126100
Status:
COMPLETED
Last Update Posted:
2007-11-26
First Post:
2005-08-01
Brief Title:
Bone Marrow Stem Cell Mobilisation Therapy for Acute Myocardial Infarction AMIREVIVAL-2
Sponsor:
Deutsches Herzzentrum Muenchen
Organization:
Deutsches Herzzentrum Muenchen
Study Overview
Official Title:
A Randomized Clinical Trial of Stem Cell Mobilization by Granulocyte-Colony-Stimulating Factor in Patients With Acute Myocardial Infarction Regenerate Vital Myocardium by Vigorous Activation of Bone Marrow Stem Cells REVIVAL-2 Trial
Status:
COMPLETED
Status Verified Date:
2007-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether stem cell mobilization by granulocyte colony-stimulating factor G-CSF therapy in patients with acute myocardial infarction after successful mechanical reperfusion reduces infarct size
Detailed Description:
Experimental studies and early-phase clinical trials suggest that transplantation of blood-derived or bone marrow-derived progenitor cells may improve cardiac regeneration after acute myocardial infarction Granulocyte colony-stimulating factor G-CSF induces mobilization of bone marrow stem cells and thereby increases the number of circulating stem cells that are available cells for myocardial regeneration
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| KKF 04-03 | None | None | None |
| KKF 10-02 | None | None | None |